Rapid Novor Inc. is a fast-growing Canadian biotechnology company specializing in antibody de novo sequencing by LC-MS/MS, software processing, and bioinformatics. The amino acid sequence of therapeutic antibody plays a critical role in the rising biopharmaceutical industry for antibody drug discovery and development, regulatory filing and intellectual property protection.
All we need is antibody sample (≥ 0.2mg, ≥95% purity).
We will deliver:
- Full sequence of heavy and light chains
- Full sequence coverage by LC-MS/MS
- Comprehensive report, and
- Raw LC-MS/MS data
within 15 business days after receiving the sample.
Choose Rapid Novor Inc., your trusted partner, and expert to restore hybridoma cell line, assure antibody product and accelerate biosimilar/antibody drug development!